Log In
BCIQ
Print this Print this
 

PXT3003

Also known as: PXT-3003

  Manage Alerts
Collapse Summary General Information
Company Pharnext S.A.S.
DescriptionOral solution of baclofen, naltrexone and sorbitol
Molecular Target Not applicable
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase III
Standard IndicationNeuropathy
Indication DetailsTreat mild to moderate Charcot-Marie-Tooth Type IA (CMT1A) disease
Regulatory Designation U.S. - Orphan Drug (Treat mild to moderate Charcot-Marie-Tooth Type IA (CMT1A) disease);
EU - Orphan Drug (Treat mild to moderate Charcot-Marie-Tooth Type IA (CMT1A) disease)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today